Co-Diagnostics, Inc. Announces Third Quarter 2025 Earnings Release Date and Webcast

Core Viewpoint - Co-Diagnostics, Inc. is set to release its third quarter 2025 financial results on November 13, 2025, and will host a conference call to discuss these results with analysts [1]. Company Overview - Co-Diagnostics, Inc. is a molecular diagnostics company based in Utah, specializing in the development, manufacturing, and marketing of advanced diagnostic technologies [3]. - The company's proprietary technology is utilized for tests designed to detect and analyze nucleic acid molecules (DNA or RNA) [3]. - Co-Diagnostics also designs specific tests for its Co-Dx PCR at-home and point-of-care platform, which is subject to regulatory review and is not currently for sale [3]. Upcoming Events - The financial results conference call will take place at 4:30 p.m. ET on the same day as the results release, featuring management including the CEO, CFO, and Head of Investor Relations [1]. - The conference call and webcast will be accessible via the company's website and a toll-free conference call number [2].